736 / 1578
Recommendation for reporting
•
Level 2 reporting should include:
Ø
Brief clinical history including description of the clinical examination, location,
diagnostic technique used, histopathological evaluation if any, staging, prior
treatment, performance status.
Ø
Treatment intent (i.e., palliative, curative)
Ø
Patient simulation
(i.e., immobilization devices, accessories, planning
image acquisition, and protocols)
Ø
Target volumes and OAR selection and delineation (
GTV, CTV, ITV, PTV;
OAR, PRV, RVR
; in cm
3
)
Ø
Planning aims and dose–volume constraints
Ø
Description of treatment planning system
(i.e., algorithm, voxel size,
calculation dose grid, type-A uncertainty for MC-based systems)
Ø
Prescription
Ø
Patient-specific QA
Ø
Delivery (i.e., treatment unit and energy, image verification device, and data
set)
Ø
DOSE REPORTING
SBRT 2017 - D. Verellen